| Concordance between biopsy and radical prostatectomy pathology in the era of targeted biopsy: a systematic review and meta-analysis S Goel, JE Shoag, MD Gross, BAH Al Awamlh, B Robinson, F Khani, ... European Urology Oncology 3 (1), 10-20, 2020 | 95 | 2020 |
| Healthcare costs of post-prostate biopsy sepsis MD Gross, MN Alshak, JE Shoag, AA Laviana, MA Gorin, A Sedrakyan, ... Urology 133, 11-15, 2019 | 47 | 2019 |
| Multicenter analysis of clinical and MRI characteristics associated with detecting clinically significant prostate cancer in PI-RADS (v2. 0) category 3 lesions BAH Al Awamlh, LS Marks, GA Sonn, S Natarajan, RE Fan, MD Gross, ... Urologic Oncology: Seminars and Original Investigations 38 (7), 637. e9-637. e15, 2020 | 25 | 2020 |
| Impact of prebiopsy magnetic resonance imaging on biopsy and radical prostatectomy grade concordance JE Shoag, PY Cai, MD Gross, C Gaffney, D Li, J Mao, M Nowels, ... Cancer 126 (13), 2986-2990, 2020 | 24 | 2020 |
| Persistent discordance in grade, stage, and NCCN risk stratification in men undergoing targeted biopsy and radical prostatectomy MN Alshak, N Patel, MD Gross, D Margolis, JC Hu Urology 135, 117-123, 2020 | 22 | 2020 |
| The Future is Female: The Influence of Female Faculty and Resident Representation on Female Applicant Match Rate Amongst Urology Residency Programs Over 3 Years A Kapur, M Hung, K Wang, M Gross, W Lee, S Weissbart, J Kim Urology 160, 46-50, 2022 | 16 | 2022 |
| Prostate multiparametric magnetic resonance imaging features following partial gland cryoablation BAH Al Awamlh, DJ Margolis, MD Gross, S Natarajan, A Priester, ... Urology 138, 98-105, 2020 | 14 | 2020 |
| SPARED collaboration: patient selection for partial gland ablation in men with localized prostate cancer MD Gross, A Sedrakyan, FJ Bianco, PR Carroll, TJ Daskivich, SE Eggener, ... The Journal of Urology 202 (5), 952-958, 2019 | 11 | 2019 |
| Assessing treatment-related toxicity using administrative data, patient-reported outcomes, or physician-graded toxicity: where is the truth? MD Gross, BAH Al Awamlh, JC Hu Seminars in Radiation Oncology 29 (4), 333-337, 2019 | 8 | 2019 |
| Is in-office transperineal biopsy the future of prostate cancer diagnosis? MD Gross, JE Shoag, JC Hu Current Opinion in Urology 29 (1), 25-26, 2019 | 8 | 2019 |
| Variation in magnetic resonance imaging-ultrasound fusion targeted biopsy outcomes in Asian American men: a multicenter study MD Gross, LS Marks, GA Sonn, DA Green, GJ Wang, JE Shoag, ... The Journal of Urology 203 (3), 530-536, 2020 | 7 | 2020 |
| Fluid intake and urinary symptoms in patients with multiple sclerosis J Tam, MD Gross, A Cheung, PM Melville, JM Kim, SJ Weissbart Journal of Urology 204 (6), 1284-1289, 2020 | 6 | 2020 |
| Trends of mesh utilization for stress urinary incontinence before and after the 2011 Food and Drug Administration notification between FPMRS-certified and non-FPMRS-certified … AR Siegal, Z Huang, MD Gross, S Mehraban-Far, SJ Weissbart, JM Kim Urology 150, 151-157, 2021 | 3 | 2021 |
| Donor-Derived Renal Cell Carcinoma in a Kidney Allograft: A Case Report MD Gross, M Hassanein, JL Myles, JJ Augustine, A Wee Transplantation Proceedings 54 (1), 123-125, 2022 | 2 | 2022 |
| Race and prostate imaging: implications for targeted biopsy and image-based prostate cancer interventions MD Gross, BAH Al Awamlh, JE Shoag, E Mauer, S Banerjee, DJ Margolis, ... BMJ Surgery, Interventions, & Health Technologies 1 (1), 2019 | 2 | 2019 |
| Editorial Comment on “Preoperative Computed Tomography Imaging Accurately Identifies Adrenal Gland Involvement In Patients With Renal Masses” MD Gross, RA Campbell Urology 194, 150-151, 2024 | | 2024 |
| Decision regret and long‐term success rates after ventral buccal mucosa graft urethroplasty JE Santiago, MD Gross, JP Accioly, BB Voelzke, BN Breyer, RK Khouri, ... BJU international, 2024 | | 2024 |
| Will long term oncologic follow-up make the case for robotic assisted radical cystectomy? MD Gross, BAH Al Awamlh, JC Hu Translational Andrology and Urology 7 (Suppl 6), S696, 2018 | | 2018 |
